Overview
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
Description
Consecutive patients receiving New DES without a mixture of other DES
Eligibility
Inclusion Criteria:
- coronary disease amenable to percutaneous coronary intervention (PCI)
- no clinical and lesion limitations
Exclusion Criteria:
- patients with a mixture of several DES
- terminal illness with life expectancy less than 1 year
- patients with cardiogenic shock